Jones Financial Companies
TELO icon

Jones Financial Companies’s Telomir Pharmaceuticals TELO Stock Holding History

Jones Financial Companies’s Portfolio TELO Stock Details TELO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$750 Hold
600
– – ﹤0.01% 4424
2025
Q4 		$798 Hold
600
– – ﹤0.01% 4069
2025
Q3 		$834 Hold
600
– – ﹤0.01% 3938
2025
Q2 		$918 Buy
600
+162
+37% +$374 ﹤0.01% 3675
2025
Q1 		$1.73K Buy
+438
New +$1.91K ﹤0.01% 3276
2024
Q4 		– Sell
-181
Closed -$1.23K – 3522
2024
Q3 		$1.23K Buy
+181
New +$882 ﹤0.01% 2773

Other funds holding TELO

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WIA
World Investment Advisors Santa Barbara, California $6.2B AUM 19.68% 1-Year Est. Return

Jones Financial Companies's TELO Position: Q1 2026 in Review

Jones Financial Companies held its Telomir Pharmaceuticals (TELO) position steady in Q1 2026 at 600 shares worth $750. The position accounts for ﹤0.01% of the portfolio, ranked #4424.

Jones Financial Companies first reported a position in TELO in Q3 2024 and has held it in 6 quarters since. The position peaked at $1.73K in Q1 2025. 27 funds tracked by Wall St. Rank hold TELO as of Q1 2026.

  • Jones Financial Companies held 600 shares of Telomir Pharmaceuticals worth $750 as of Q1 2026.
  • Jones Financial Companies left its Telomir Pharmaceuticals share count unchanged in Q1 2026.
  • Telomir Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4424 holding.
  • Jones Financial Companies first reported a position in Telomir Pharmaceuticals in Q3 2024 and has held it in 6 quarters since.
  • Jones Financial Companies's Telomir Pharmaceuticals position peaked at $1.73K in Q1 2025.
  • 27 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.